The value of SCORAD and beyond. Towards a standardized evaluation of severity?

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 59, Issue 78, 2004, Pages 61-65

  Gelmetti, C ^a,b   Colonna, ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Atopic dermatitis; SCORAD; Scoring systems; Severity criteria

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENTEROTOXIN; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; MAJOR BASIC PROTEIN;

ATOPIC DERMATITIS; BASOPHIL; CONFERENCE PAPER; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EOSINOPHIL; HUMAN; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; STANDARD; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

DERMATITIS, ATOPIC; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 3442899722     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. HANIFIN JM, RAJKA G. Diagnostic features of atopic dermatitis. Acta Dermatol Venerol (Stockh) 1980;92:44-47.
2. WILLIAMS HC, BURNEY PG, HAY RJ, et al. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383-396.
3. RAJKA G, LANGELAND T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989;144:13-14.
4. COSTA C, RILLIET A, NICOLET M, SAURAT JH. Scoring atopic dermatitis: the simpler the better? Acta Derm Venereol (Stockh) 1989;69:41-45.
5. BAHMER FA, SHÄFER J, SCHUBERT HJ. Quantification of the extent and the severity of atopic dermatitis: the ADASI score. Arch Dermatol 1991;127:1239-1240.
6. BAHMER FA. ADASI score: atopic dermatitis area and severity index. Acta Derm Venereol (Suppl)(Stockh) 1992;176:32-33.
7. EUROPEAN TASK FORCE ON ATOPIC DERMATITIS. Severity scoring of atopic dermatitis; the SCORAD index. Dermatology 1993;186:23-31.
8. KUNZ B, ORANJE AP, LABREZE L, STALDER JF, RING J, TAÏEB A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19.
9. WOLKERSTORFER A, DE WAARD VAN DER SPEK FB, GLAZENBURG EJ, MULDER PG, ORANJE AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 1999;79:356-359.
10. BERTH-JONES J. Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996;135:25-30.
11. CHARMAN CR, VENN AJ, WILLIAMS HC. Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score. Br J Dermatol 2002;146:1057-1060.
12. HANIFIN JM, THURSTON M, OMOTO M, CHERILL R, TOFTE SJ, GRAEBER M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group Exp Dermatol 2001;10:11-18.
13. HOUSMAN TS, PATEL MJ, CAMACHO F, FELDMAN SR, FLEISCHER AB JR, BALKRISHNAN R. Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study. Br J Dermatol 2002;147:1192-1198.
14. JEMEC GB, WULF HC. The applicability of clinical scoring systems. SCORAD and PASI in psoriasis and atopic dermatitis. Acta Derm Venereol 1997;77:392-393.
15. SPRIKKELMAN AB, TUPKER RA, BURGERHOF H, SCHOUTEN JP, BRAND PL, HEYMANS HS et al. Severity scoring of atopic dermatitis: a comparison of three scoring systems. Allergy 1997;52:944-949.
16. ORANJE AP, STALDER JF, TAÏEB A, TASSET C, DE LONGUEVILLE M. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group Early Treatment Atopic Child. Pediatr Allergy Immunol 1997;8:28-34.
17. CZECH W, KRUTMANN J, SCHOPF E, KAPP A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-355.
18. JAMES JM, KAGEY-SOBOTKA A, SAMPSON HA. Patients with severe atopic dermatitis have activated circulating basophils. J Allergy Clin Immunol 1993;91:1155-1162.
19. MORITA H, YAMAMOTO K, KITANO Y. Elevation of serum major basic protein in patients with atopic dermatitis. J Dermatol Sci 1995;9:165-168.
20. MORITA H, KITANO Y, KAWASAKI N. Elevation of serum-soluble E-selectin in atopic dermatitis. J Dermatol Sci 1995;10:145-150.
21. NOMURA I, TANAKA K, TOMITA H, KATSUNUMA T, OHYA Y, IKEDA N et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999;104:441-446.
22. TOYODA M, NAKAMURA M, MAKINO T, HINO T, KAGOURA M, MOROHASHI M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:71-79.
23. LEUNG TF, MA KC, HON KL, LAM CW, WAN H, LI CY et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003;14:296-301.
24. JORIZZO J, LEVY M, LUCKY A, SHAVIN J, GOLDBERG G, DUNLAP F et al. Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 1995;33:74-77.
25. EICHENFIELD LF, LUCKY AW, BOGUNIEWICZ M, LANGLEY RG, CHERILL R, MARSHALL K, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002;46:495-504.